Literature DB >> 4856474

[Problem of the cholestatic jaundice in the newborn infant].

M Negri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4856474

Source DB:  PubMed          Journal:  Minerva Med        ISSN： 0026-4806            Impact factor:   4.806


× No keyword cloud information.
  9 in total

1.  Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence.

Authors:  Sevin Turcan; Vladimir Makarov; Julian Taranda; Yuxiang Wang; Armida W M Fabius; Wei Wu; Yupeng Zheng; Nour El-Amine; Sara Haddock; Gouri Nanjangud; H Carl LeKaye; Cameron Brennan; Justin Cross; Jason T Huse; Neil L Kelleher; Pavel Osten; Craig B Thompson; Timothy A Chan
Journal:  Nat Genet       Date:  2017-11-27       Impact factor: 38.330

2.  Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.

Authors:  Mizuki Kobayashi; Nobuhiro Fujiyama; Tokiyoshi Tanegashima; Shintaro Narita; Yoshiaki Yamamoto; Naohiro Fujimoto; Shohei Ueda; Ario Takeuchi; Kazuyuki Numakura; Tomonori Habuchi; Hideyasu Matsuyama; Masatoshi Eto; Masaki Shiota
Journal:  Cancer Immunol Immunother       Date:  2021-08-11       Impact factor: 6.968

Review 3.  Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data.

Authors:  Ashton A Connor; Steven Gallinger
Journal:  Nat Rev Cancer       Date:  2021-11-17       Impact factor: 60.716

4.  The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.

Authors:  Shogo Kumagai; Yosuke Togashi; Takahiro Kamada; Eri Sugiyama; Hitomi Nishinakamura; Yoshiko Takeuchi; Kochin Vitaly; Kota Itahashi; Yuka Maeda; Shigeyuki Matsui; Takuma Shibahara; Yasuho Yamashita; Takuma Irie; Ayaka Tsuge; Shota Fukuoka; Akihito Kawazoe; Hibiki Udagawa; Keisuke Kirita; Keiju Aokage; Genichiro Ishii; Takeshi Kuwata; Kenta Nakama; Masahito Kawazu; Toshihide Ueno; Naoya Yamazaki; Koichi Goto; Masahiro Tsuboi; Hiroyuki Mano; Toshihiko Doi; Kohei Shitara; Hiroyoshi Nishikawa
Journal:  Nat Immunol       Date:  2020-08-31       Impact factor: 25.606

5.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.

Authors:  Peng Jiang; Shengqing Gu; Deng Pan; Jingxin Fu; Avinash Sahu; Xihao Hu; Ziyi Li; Nicole Traugh; Xia Bu; Bo Li; Jun Liu; Gordon J Freeman; Myles A Brown; Kai W Wucherpfennig; X Shirley Liu
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

Review 6.  Emerging role of PTEN loss in evasion of the immune response to tumours.

Authors:  Thiago Vidotto; Camila Morais Melo; Erick Castelli; Madhuri Koti; Rodolfo Borges Dos Reis; Jeremy A Squire
Journal:  Br J Cancer       Date:  2020-04-24       Impact factor: 7.640

7.  Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition.

Authors:  Jenny H Lee; Elena Shklovskaya; Su Yin Lim; Matteo S Carlino; Alexander M Menzies; Ashleigh Stewart; Bernadette Pedersen; Malama Irvine; Sara Alavi; Jean Y H Yang; Dario Strbenac; Robyn P M Saw; John F Thompson; James S Wilmott; Richard A Scolyer; Georgina V Long; Richard F Kefford; Helen Rizos
Journal:  Nat Commun       Date:  2020-04-20       Impact factor: 14.919

8.  Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma.

Authors:  Man Hsin Hung; Joo Sang Lee; Chi Ma; Laurence P Diggs; Sophia Heinrich; Ching Wen Chang; Lichun Ma; Marshonna Forgues; Anuradha Budhu; Jittiporn Chaisaingmongkol; Mathuros Ruchirawat; Eytan Ruppin; Tim F Greten; Xin Wei Wang
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

9.  Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers.

Authors:  Yongsheng Li; Tiantongfei Jiang; Weiwei Zhou; Junyi Li; Xinhui Li; Qi Wang; Xiaoyan Jin; Jiaqi Yin; Liuxin Chen; Yunpeng Zhang; Juan Xu; Xia Li
Journal:  Nat Commun       Date:  2020-02-21       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.